Adagene Inc.: Form 20-F for the period ended Dec 31, 2025
Filed with the SEC on Apr 1, 2026 and accepted by EDGAR at Apr 1, 2026, 17:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2025-01-01 to 2025-12-31 | $7.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2025-01-01 to 2025-12-31 | $22.0m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2025-01-01 to 2025-12-31 | −$21.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2025-01-01 to 2025-12-31 | $463.1k | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months2025-01-01 to 2025-12-31 | −$297.9k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2025-01-01 to 2025-12-31 | −$17.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2025-01-01 to 2025-12-31 | −$0.30 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2025-01-01 to 2025-12-31 | −$0.30 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2025-01-01 to 2025-12-31 | 59,006,129 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2025-01-01 to 2025-12-31 | −$15.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2025-01-01 to 2025-12-31 | $17.1k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2025-12-31 | $74.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2025-12-31 | $77.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2025-12-31 | $78.3m | us-gaap:Assets |
| Current liabilities | At period end2025-12-31 | $25.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2025-12-31 | $26.4m | us-gaap:Liabilities |
| Long-term debt | At period end2025-12-31 | $1.1m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2025-12-31 | $711.4k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2025-12-31 | $35.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2025-12-31 | 59,231,993 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-26-038612. Last ingested by Listed: Nov 9, 2026, 17:22 ET. Listed shows no prices and gives no investment advice.